Azioni Acerus Pharmaceuticals Corporation Toronto S.E.
Azioni
ASP
CA00444G4051
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+29,98% | 684 Mrd | |
+30,34% | 568 Mrd | |
-3,52% | 361 Mrd | |
+18,59% | 329 Mrd | |
+4,07% | 284 Mrd | |
+16,21% | 240 Mrd | |
+9,66% | 208 Mrd | |
-6,83% | 200 Mrd | |
+7,09% | 166 Mrd |